NEWS DESK

SLXNW Stock News, News Score & What It Could Mean

Silexion Therapeutics Corp - Warrant (SLXNW) is currently showing a slightly bearish headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: There is a mild negative lean in the higher-value headlines, though the setup is not strong enough to call decisively bearish.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
41/100
Slightly Bearish
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Medium
Headline depth
Last Price
$0.03
Trend Context
Mixed / range
Latest briefing

What's happening with SLXNW

dars.gov.et24 Jun 2026

Silexion Therapeutics Warrants (SLXNW) Hold Flat at $0.03 as Range Tightens - Composite Profile - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPNWdqU0lqVWhPdEx3OUEyeTdRZmVNd3VRN0pLdXBseG5OLXJsYVhYMnJOWUNKUUQ5QUNTSnUtT3ZmdWpsMVBRQmNlNEEyQW9xeWdoT3pTb2pFdzgxekdyNVZXZVBFQVY2NG5BVlhYNFdWWExNUlYyeUVySnc1X1FiZzFUUGdaWXpWMnA2QXl2LVhabnBYTzVvOHlEbmpIaG9rRUp4NjZvQy1YWXJlOTNsdnhGOGtlQQ?oc=5" target="_blank">Silexion Therapeutics Warrants (SLXNW) Hold Flat at $0.03 as Range Tightens - Composite Profile</a>&nbsp;&nbsp;<font color="#6f6f6f">dars.gov.et</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
DonanımHaber10 Jun 2026

Silexion Therapeutics Warrants (SLXNW) Plunge 33% as Support at $0.03 Faces Test - Moving Average Ribbon - DonanımHaber

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNTUwTnZCckxZaVVjTmxQdjRUblR6a2pQSXF0OUR2MHVUQnh1V3U1dEZFelVqN2xXaFMxdGFGN0lHMkxOeklxS01ZX3NFSWdqY3F2RzdYOElSclF3dEVxbkh3TXJjVDRRdnctc09wRDYxVWxBUjFaT1RKMndsNFJkU3ZTcTJ3RUk2UDNNdngtRUYxUHZMeXdmZUJzaG5CNWs2ZS1wMlhfeEMtSDZFbXhqVmFTX1FGRzk0OWIwZ2hpNzE?oc=5" target="_blank">Silexion Therapeutics Warrants (SLXNW) Plunge 33% as Support at $0.03 Faces Test - Moving Average Ribbon</a>&nbsp;&nbsp;<font color="#6f6f6f">DonanımHaber</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
GlobeNewswire15 May 2026

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxNV2VFTlBDbkhkZVU2UjA0eXh1T1Ytck5Fekd1OUdmMXk1dkVGdlZlRUFlSDEtVWlvRm5TQXNLTDgtX2J4OXVBdkFJRmM2Ym0taFhzOTVGQTZjUDhFNC1IUnNsN1UzenpveWI5b254RlVVd3NsS2RNanVBQXg4Zk5VTnRPWU9zdXdzUnQzRzl1RGt6THNwRzNlLVhjTWZTYkhPQmlWNGpmU0dIZnQ0ZU5TYWs0a2ZqdGF5Y1J2eXJXcnM3ZndGaC1PN1FMd3Y0bVFaUG51b09lS21RVzZOMjYzWnRDcjZGSk15?oc=5" target="_blank">Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</…

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
TradingView
18 Aug 2024
SLXNW Stock Warrant Price and Chart — NASDAQ:SLXNW - TradingView
Read ↗
Earnings news

SLXNW earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
GlobeNewswire26 May 2026

Silexion Therapeutics Announces 1-for-10 Reverse Share Split - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOc0pWeTZRVTNnNXhUWnVqZUhGX2lVeGdIREg4LVJiSnQ5cGNkUUZERG9YZkZhNzZLb1pQMUdMS1FPNzFkUjZYQ2NpR3BhdEJXOWVoWlAxLVFIUVQtNkhoQjJoTkNHYU5QYWZsaEU0cmZON3ZXUFdaZTFfWTJDTGZ5RGRFNE1YU3BCekJaUm41aTVrWk9yTFFOdWswSTN4VWlTdDRxTENRR1lKVGpMenk3ekhYVFF1MkdOZWtnUFBDSFJLYUtrallSTDBXOV8?oc=5" target="_blank">Silexion Therapeutics Announces 1-for-10 Reverse Share Split</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>

2
GlobeNewswire18 May 2026

Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPQVhHZmZxUV9hdk03TjgycFVCWU04S1ZGamYxVkt0bk5RRHNDdEt6VTkwNjdyYzRVWGJhbC11RzNFTExUX1RpOTVacmFVMnYxM2N4SG5hWklvb0tVTVplUXFDVmptRnpFSW52bXJUcG9PYVJ3UnR6eUZzT1dDaHEyb1pfdGo0UlJIWDF2NGVhTlhHQVlLb01UdWJFTHJ4Y0FqekJXR3IwcGE2WDg2T2tDV2MxdnYxaERCVkQwaUNVdVFpMDRXWUZXMGhBbUp1UFBMVG9SM09kOHIwWWdrdGN4ZUVEdGlkUGZtS0VWd0ZBLXVBWlRIN1VKdjdsZw?oc=5" target="_blank">Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your SLXNW research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.